Showing results (191-200 of 355) with videos related to

Sort By:
Pageof 36
European Heart Journal|March 24, 2022
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trialScott D Solomon, Brian L Claggett, Zi Michael Miao, et al.
Lancet (London, England)|March 8, 2023
Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
European Heart Journal|January 28, 2025
Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trialAlexander Peikert, Muthiah Vaduganathan, Brian L Claggett, et al.
The Lancet. Diabetes & Endocrinology|January 16, 2025
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trialJawad H Butt, Pardeep S Jhund, Alasdair D Henderson, et al.
European Journal of Heart Failure|March 2, 2026
Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trialYasuhiro Hamatani, Brian L Claggett, Ian J Kulac, et al.
European Journal of Heart Failure|May 22, 2023
Electronic nudges to increase influenza vaccination uptake among patients with heart failure: A pre-specified analysis of the NUDGE-FLU trialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
JACC. Heart Failure|December 9, 2025
Finerenone-Related Risk of Hypotension in Heart Failure With Mildly Reduced or Preserved Ejection FractionAlberto Foà, Muthiah Vaduganathan, Brian L Claggett, et al.
Respiratory Investigation|November 2, 2025
Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trialLisa Steen Duus, Niklas Dyrby Johansen, Daniel Modin, et al.
Human Vaccines & Immunotherapeutics|January 8, 2026
A Bayesian re-analysis of the DANFLU-1 trialDaniel Modin, Niklas Dyrby Johansen, Anders Granholm, et al.
European Journal of Heart Failure|July 17, 2024
Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: An analysis of DAPA-HF and DELIVERAmr Abdin, Toru Kondo, Michael Böhm, et al.
Pageof 36